Role of HRCT Chest in Post Stem Cell Transplant Recipients Suspected of Pulmonary Complications

被引:3
|
作者
Dwivedi, Abhishek [1 ]
Kumar, R. Ravi [2 ]
Sharma, Ajay [3 ]
Pannu, S. K. [1 ]
机构
[1] Army Hosp Res & Referral, Dept Radiodiag, Radiol, New Delhi 110010, India
[2] Army Hosp Res & Referral, Dept Diagnost & Intervent Radiol, New Delhi, India
[3] Army Hosp Res & Referral, Dept Haematol & Stem Cell Transplant, New Delhi, India
关键词
Graft vs. host disease; Immunosuppression; Neutropenia; Sepsis;
D O I
10.7860/JCDR/2016/24387.8885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Stem cell transplantation is today's procedure of choice for management of various hematopoietic malignant and severe immunogenic disorders. High Resolution Computed Tomography (HRCT) is a common technique for the diagnosis of pulmonary complications in stem cell transplant recipients. There are a large number of complications which can complicate the post-transplant period. Aim: To study the role of HRCT chest in stem cell transplant patients developing pulmonary complications, detect any evidence of infection, detect clinical signs of lung infections, Graft versus Host Disease (GvHD) or other regimen related toxicities outlined earlier, detect any evidence of GvHD and correlate these clinical signs with radiological changes in the lungs. Materials and Methods: The study was a prospective study of 52 participants with indication of stem cell transplantation. The study included recipients of HSCT transplant and the exclusion criteria was patients who failed for engraftment and having an associated history of pulmonary embolism. Patients were screened for pre-transplant chemotherapy, clinical examination, laboratory investigations including blood and biochemical examinations, imaging by ultrasound, chest radiography, baseline HRCT and a follow-up for post-transplant infections and complications with 16 slice Siemens CT scan. Statistical analysis was done using Pearson's chi-squared test. Results: Four patients among the total 56 were excluded due to non-engraftment. The most common associated findings in decreasing order are (these patients died): consolidation, pancytopenia and gastrointestinal tract symptoms with VOD (Veno-Occlusive Disease). These findings were seen on HRCT as consolidation, cavities, ground glass opacities, fibrotic changes, bronchiectatic changes and tree in bud appearance. Conclusion: The study highlights the significant positive findings on the HRCT which were missed on routine chest radiograph and can be used for early diagnoses. Thus, HRCT helped in decreasing the mortality. The abnormal vitals and TLC counts showed a significant relation between the numbers of death in the study.
引用
收藏
页码:TC18 / TC23
页数:6
相关论文
共 50 条
  • [1] Pulmonary Complications in Hematopoietic Stem Cell Transplant Recipients-A Clinician Primer
    Astashchanka, Anna
    Ryan, Joseph
    Lin, Erica
    Nokes, Brandon
    Jamieson, Catriona
    Kligerman, Seth
    Malhotra, Atul
    Mandel, Jess
    Joshua, Jisha
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [2] Pulmonary complications post allogeneic haematopoietic stem cell transplant in children
    Walker, Hannah
    Abbotsford, Joanne
    Haeusler, Gabrielle M.
    Yeoh, Daniel
    Ramachandran, Shanti
    Ng, Michelle
    Holzmann, Jonathan
    Shanthikumar, Shivanthan
    Weerdenburg, Heather
    Hanna, Diane
    Neeland, Melanie R.
    Cole, Theresa
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2024, 13 (09)
  • [3] Early infectious pulmonary complications in autologous hematopoietic stem cell transplant (HSCT) recipients
    Mahmoud, AA
    Litzow, MR
    Peters, SG
    Dispenzieri, A
    Tefferi, A
    Afessa, B
    CHEST, 2005, 128 (04) : 184S - 184S
  • [4] PULMONARY COMPLICATIONS IN TRANSPLANT RECIPIENTS
    SIMMONS, RL
    URANGA, VM
    BUSELMEIER, TJ
    NAJARIAN, JS
    KJELLSTRAND, CM
    ARCHIVES OF SURGERY, 1972, 105 (02) : 260 - +
  • [5] Post-transplant complications -: Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients
    Jenkins, D
    DiFrancesco, L
    Chaudhry, A
    Morris, D
    Glück, S
    Jones, A
    Woodman, R
    Brown, CB
    Russell, J
    Stewart, DA
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 321 - 326
  • [6] Pulmonary enterovirus infections in stem cell transplant recipients
    Y González
    R Martino
    I Badell
    N Pardo
    A Sureda
    S Brunet
    J Sierra
    N Rabella
    Bone Marrow Transplantation, 1999, 23 : 511 - 513
  • [7] Pulmonary enterovirus infections in stem cell transplant recipients
    González, Y
    Martino, R
    Badell, I
    Pardo, N
    Sureda, A
    Brunet, S
    Sierra, J
    Rabella, N
    BONE MARROW TRANSPLANTATION, 1999, 23 (05) : 511 - 513
  • [8] Spectrum of pulmonary pathology in stem cell transplant recipients
    Dimov, Nikolay D.
    Zynger, Debra L.
    Yeldandi, Anjana V.
    MODERN PATHOLOGY, 2006, 19 : 165 - 165
  • [9] The role of busulfan at post transplant pulmonary complications in allogeneic hematopoietic cell transplantation
    Soydan, E
    Arat, M
    Ozdemir Kumbasar, O
    Ozcan, M
    Arslan, O
    Gurman, G
    Koc, H
    Iihan, O
    Beksac, M
    Alper, D
    Akan, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S188 - S188
  • [10] Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant
    Walker, Hannah
    Haeusler, Gabrielle M.
    Cole, Theresa
    Neeland, Melanie
    Hanna, Diane
    Shanthikumar, Shivanthan
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2024, 13 (09)